Evotec and Owkin enter an A.I.-powered strategic partnership to accelerate therapeutics pipeline in oncology and I&I

04-Jan-2024 - Evotec SE and Owkin, a French-American techbio startup announced an A.I.-powered integrated multi-target collaboration in oncology, immunology and inflammation (“I&I”). The collaboration brings together highly complementary platforms and expertise to accurately select targets, discover and ...

LDC and JT team up for the discovery of new therapies

12-Oct-2023 - The Lead Discovery Center GmbH (LDC) and Japan Tobacco Inc. (JT) have closed a collaboration agreement to discover new first-in-class therapeutic approaches, focusing around novel chemical entities for the treatment of various diseases with significant unmet medical need. Over a period of up to ...

SAS accelerates delivery of novel medicines using AI and analytics

Cooperation with AstraZeneca for more innovation in clinical research

12-Oct-2023 - SAS, a leader in AI and analytics, is helping to revolutionize the use of clinical trial data so new medicines can be delivered to patients faster than before. After a thorough evaluation, SAS has been chosen by global biopharmaceutical company AstraZeneca to help increase efficiency and drive ...

New incubator to promote drug discovery and create new therapeutics companies in Singapore

Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch "65LAB"

06-Oct-2023 - Evotec SE announced that the Company has entered into a new BRIDGE partnership with Lightstone Ventures, ClavystBio, Leaps by Bayer, Polaris Partners, and the Polaris Innovation Fund. “65LAB”, Evotec’s first academic BRIDGE in Asia, aims to advance drug discovery and the creation of new ...

Waters Corporation and Princeton University Announce Multi-Year Research Collaboration

Agreement to take on real-world challenges in biologics and materials research

28-Jun-2023 - Waters Corporation announced a multi-year research collaboration with Princeton University that will enable scientists, faculty, and students to work together to bring theirdiverse skills and backgrounds to solve complex challenges in biochemistry and materials science. "Solving the biggest ...

Insilico Medicine-led study combines quantum computing and generative AI for drug discovery

“Quantum computing is recognized as the next technology breakthrough which will make a great impact, and the pharmaceutical industry is believed to be among the first wave of industries benefiting from the advancement”

25-May-2023 - Insilico Medicine, a clinical stage generative artificial intelligence (AI)-driven drug discovery company, announced that it combined two rapidly developing technologies, quantum computing and generative AI, to explore lead candidate discovery in drug development and successfully demonstrated the ...

Use of Artificial Intelligence in Drug Development

WACKER, CordenPharma, LMU and HU Berlin Train Machine Learning Algorithm for the Formulation of RNA Actives

03-Apr-2023 - Together with Munich’s Ludwig Maximilian University (LMU) and the Humboldt University of Berlin (HU Berlin), Wacker Chemie AG and CordenPharma International GmbH have launched a project to accelerate the development of RNA-based drugs. The aim is to develop a new generation of lipid nanoparticles ...

Insilico Medicine brings AI-powered “ChatPandaGPT” to its target discovery platform

A revolution in drug discovery thanks to a new chat assistant?

16-Mar-2023 - Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-powered drug discovery company, has integrated advanced AI chat functionality based on recent advances in large language models into its PandaOmics platform. The new feature, “ChatPandaGPT,” enables researchers to have ...

"Dr Jekyll and Mr Hyde" technique to fight cancer

Viennese start-up develops novel, precise anti-cancer drugs

06-Mar-2023 - RIANA Therapeutics, a promising pharmaceutical start-up recently spun out of the University of Veterinary Medicine Vienna (Vetmeduni), aims to develop novel therapeutics for cancer patients based in part on scientific findings from Vetmeduni’s Moriggl research group (Moriggl Lab). The ...

Bayer to Accelerate Drug Discovery with Google Cloud’s High-Performance Compute Power

12-Jan-2023 - Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud’s Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run cutting-edge machine learning models and computationally-intensive workloads, to help accelerate ...